Promacta (eltrombopag olamine) — Highmark
thrombocytopenia in chronic hepatitis C to allow initiation and maintenance of interferon-based therapy
Preferred products
- generic eltrombopag olamine
Initial criteria
- used to achieve target platelet counts to initiate or maintain interferon therapy in patients with chronic hepatitis C
- platelet count < 75 x 10^9/L
- if request is for brand Promacta, therapeutic failure or intolerance to generic eltrombopag olamine